Literature DB >> 9491527

Evaluation of primary haemostasis in canine leishmaniasis.

P Moreno1, R Lucena, P J Ginel.   

Abstract

Primary haemostasis was evaluated by measurements of bleeding time and platelet count in 26 dogs with leishmaniasis and 10 normal dogs. Bleeding time was significantly (P = 0.02) longer in the infected dogs than in the control group, and in infected dogs with creatinine concentrations > 1.5 mg/dl than in infected dogs with normal creatinine levels. There was a significant linear regression between the concentration of creatinine and bleeding time (P = 0.02) although the coefficient of determination was low (r2 = 0.194). There were no significant differences in platelet counts between the normal and diseased dogs, and there were no significant differences between male and female dogs in either group.

Entities:  

Mesh:

Year:  1998        PMID: 9491527     DOI: 10.1136/vr.142.4.81

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Haemostatic disorders in dogs naturally infected by Leishmania infantum.

Authors:  M Corona; P Ciaramella; A Pelagalli; L Cortese; M E Pero; D Santoro; P Lombardi
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

2.  Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity.

Authors:  Adriane Pimenta da Costa-Val; Reginaldo Roris Cavalcanti; Nelder de Figueiredo Gontijo; Marilene Suzan Marques Michalick; Bruce Alexander; Paul Williams; Maria Norma Melo
Journal:  Vet J       Date:  2007-01-16       Impact factor: 2.688

3.  Disseminated intravascular coagulation in a dog naturally infected by Leishmania (Leishmania) chagasi from Rio de Janeiro - Brazil.

Authors:  Carla O Honse; Fabiano B Figueiredo; Nayro X de Alencar; Maria de Fátima Madeira; Isabella D F Gremião; Tânia M P Schubach
Journal:  BMC Vet Res       Date:  2013-03-05       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.